Skip to main content
. 2020 Oct 23;11(6):398–404. doi: 10.14740/cr1159

Table 2. Comparison of Clinical Characteristics Between Non-Survivors and Survivors Groups (N = 257).

Non-survivorsb (n = 56) Survivorsc (n = 201) P value
Characteristics
  Age, mean (SDa), years 75(14) 60(17) < 0.0001*
  Sex, female (%) 29(51) 93(46) 0.4839
  Body mass index, mean (SDa), kg/m2 28(7) 29(7) 0.2907
  Race, Black (%) 6(10) 37(18) 0.3101
  Ethnicity, Hispanic (%) 13(23) 45(22) 0.9144
  Asthma (%) 3(5) 18(9) 0.3774
  Chronic obstructive lung disease (%) 2(3) 5(2) 0.6658
  Chronic kidney disease (%) 3(5) 7(3) 0.5281
  Atrial fibrillation/flutter (%) 12(21) 13(6) 0.0009*
  Diabetes mellitus (%) 21(37) 51(25) 0.0780
  Hypertension (%) 40(71) 101(50) 0.0057
  Stroke/TIA (%) 4(7) 6(3) 0.1581
  Coronary artery disease (%) 9(16) 22(11) 0.3060
  Chronic heart failure (%) 7(12) 11(5) 0.0707
  Severe valvular disease (%) 2(3) 1(0.5) 0.0594
  Coronary artery bypass graft surgery (%) 3(5) 4(2) 0.3477
  Peripheral vascular disease (%) 1(1) 7(3) 0.5131
Laboratory data at the time of admission
  Blood urea nitrogen, mean (SDa), mg/dL 37(30) 19(17) < 0.0001*
  Creatinine, mean (SDa), mg/dL 1.5(1.2) 1(0.9) 0.0097*
  Random blood glucose level, mean (SDa), mg/dL 194(128) 138(75) 0.0026*
  Absolute lymphocyte count, mean (SDa), × 103 cells/µL 1.2(1.2) 2(5.5) 0.0499*
  Sodium, mean (SDa), mEq/L 138(9) 136(4) 0.0903
  Lactic acid, mean (SDa), mmol/L 3(4) 1(0.5) 0.0035*
  Total bilirubin, mean (SDa), mg/dL 0.7(0.5) 0.5(0.2) 0.0045*
  Elevated troponind (%) 37 (66) 34(17) < 0.0001*
  Albumin, mean (SDa), mg/dL 3.5(0.4) 3.8(0.4) 0.0004*

*Statistically significant. a± SD. bNon-survivors: patients died during the index hospitalization or discharged to hospice. cSurvivors: Patients were discharged home alive. dElevated troponin: ≥ 0.012 ng/ml which falls above the 99th percentile in the blood test based on our facility’s laboratory data. SD: standard deviation; TIA: transient ischemic attack.